The QualityStocks Daily Tuesday, October 22nd, 2019

Today's Top 3 Investment Newsletters

The Street (SANP) +150.00%

Penny Pick Finders (TROV) +70.48%

HotOTC (TAUG) +53.39%

The QualityStocks Daily Stock List

Bear Creek Mining Corporation (BCEKF)

Stock Target Advisor, Northern Miner, Mining Global, OTC Markets, Whale Wisdom, Mining Stock Education, AnalystRatings, The Gold Telegraph, Market Screener, GuruFocus, Silicon Investor, TradingView, Mesa Weekly, MQWorld.com, Wallet Investor, MarketWatch, Seeking Alpha, InvestorsHub, Stockhouse, Canadian Mining Report, and Morningstar reported earlier on Bear Creek Mining Corporation (BCEKF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Bear Creek Mining Corporation is a top Peru-focused silver exploration and development company listed on the OTC Markets Group’s OTCQX. Its flagship Corani Project is one of the largest undeveloped silver deposits globally. The Company’s Executives and Directors have a considerable breadth and depth of experience discovering, advancing, financing, developing, constructing and operating mines in Latin America. Bear Creek Mining has its corporate headquarters in Vancouver, British Columbia.

The Corani deposit (besides its size and projected life-span) contains substantial base metal credits. It is situated in a mining-friendly jurisdiction and enjoys overwhelming community support. The Corani Project contains greater than 250 million ounces of silver, 2.7 billion pounds of lead, and 1.8 billion pounds of zinc.

The expectation is that the Corani Project will produce more than 8 million ounces of silver and 150 million pounds of combined lead and zinc over an 18-year mine life. Corani is highly leveraged to metal prices, with a $112 million increase in NPV (Net Present Value - the difference between the present value of cash inflows and the present value of cash outflows over a period of time ) for every $1 increase in silver price with proportional changes in lead and zinc prices.

Corani is Bear Creek Mining’s most advanced mineral property. The 100 percent owned Corani silver-lead-zinc property is in the Andes Mountains of Peru, around 160 kilometers southeast of Cusco in a sparsely populated high mountain desert environment. The project comprises 13 mineral concessions. These form a contiguous block of ground covering roughly 5,700 hectares.

Bear Creek Mining also has its exploration project - Maria Jose. The Maria Jose Prospect is situated in the Department of Ancash, 140 km NNW of Lima, Peru. This property hosts a system of mesothermal quartz veins and shear zones. These have been observed over a strike length of about 4km. They range in thickness from 0.20 meters to 1.8 meters with average widths of approximately 1 meter.

Exposed vein intersections reach up to 4.5 meters returning an average of 27.2 g/t gold. During 2015 and 2016, mapping and channel sampling of seven veins yielded values ranging from 1.0 g/t to 233 g/t gold.

Recently, Bear Creek Mining announced that its Board of Directors appointed Mr. Alan Hair as a Director of the Company effective immediately. Mr. Hair is a mining engineer and senior executive. He has more than 36 years of experience in the mining and metals industry. Mr. Hair is the former President and Chief Executive Officer of Hudbay Minerals, Inc.

Bear Creek Mining Corporation (BCEKF), closed Tuesday's trading session at $1.87, up 1.8103%, on 115,396 volume with 129 trades. The average volume for the last 3 months is 47,224 and the stock's 52-week low/high is $0.709999978/$2.04999995.

chart

Beliss Corp. (BLIS)

NetworkNewsWire, Penny Stock Hub, Simply Wall St, OTC Markets, PitchBook, Market Screener, Last10k, TipRanks, Wallet Investor, Street Insider, Macroaxis, Stock Reads, Stockhouse, PR Newswire, Morningstar, GuruFocus, MarketWatch, and InvestorsHub reported previously on Beliss Corp. (BLIS), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Beliss Corp.’s intention is to conduct shipwreck and treasure recovery from shallow shipwreck finds in the Caribbean and North America. The Company concentrates on the discovery and recovery of valuable artifacts and treasure from researched sites and shipwrecks. Beliss - Treasure & Shipwreck Recovery, Inc. (TSR) - presently trades on the OTC Market under the ticker symbol “BLIS”. Beliss has its corporate office in St. Petersburg, Florida.

The Company intends to become the largest sunken treasure recovery company globally. Its main emphasis is on ancient cargo wrecks (before 1800 wrecks), including galleons transporting gold, silver, and jewels from the New World to Europe. However, it will also target proven and claimed areas for more modern 19th century wrecks. These can contain extremely valuable and unique cargoes, such as rare intricate artifacts, jewelry, furnishings, arms, coinage, as well as other items.

Treasure & Shipwreck Recovery has its own and partnered vessels to use on its numerous shipwreck sites. Moreover, the Company intends to expand into media projects for other matters in games, television and sales of artifacts.

Dr. E Lee Spence is Chairman and Chief Operating Officer. Dr. Spence is a globally known expert on shipwrecks and sunken treasures. He received one of the first five doctorates (Doctor of Marine Histories, College of Marine Arts, 1972) ever awarded for marine archaeology anywhere worldwide. In addition, Dr. Spence has long been considered one of the founding fathers of marine archaeology. He has discovered hundreds of treasure laden and historical wrecks.

Last month, Treasure & Shipwreck Recovery announced that its brand-new cesium magnetometer was delivered on September 19, 2019. Dr. E. Lee Spence said, “This isn’t an off-the-shelf item that you can buy at your local dive shop or treasure hunting store. It’s a state-of-the-art piece of scientific equipment, costing almost $40,000. Our new magnetometer is a model G882AR/4, made to special order for us by Geometrics in San Jose, California. To my eyes, it’s a real beauty… Although a ‘mag’ can’t detect gold or silver, it can detect the iron cannons, cannon balls, muskets, pistols and cutlasses that, for centuries, were used to protect large shipments of coins and bullion, as well as other valuable cargos that could range from precious jewels to exquisite porcelain.”

Additionally, in September, Treasure & Shipwreck Recovery announced its publication of a 19-page paper entitled “A Look at the Commercial Value of Shipwrecks & Their Artifacts,” authored by Dr. Spence. This paper includes an in-depth explanation concerning the kinds of treasure and recoveries that can be made as the Company moves forward.

Beliss Corp. (BLIS), closed Tuesday's trading session at $4.10, up 11.5646%, on 3,243 volume with 11 trades. The average volume for the last 3 months is 356 and the stock's 52-week low/high is $2.00/$9.00.

chart

Corvus Gold, Inc. (CORVF)

NetworkNewsWire, Zacks, Real Investment Advice, The Street, Wallet Investor, Junior Mining Network, InvestorsHub, Investors Hangout, Stock News Now, Stock Digest, Trading View, The Daily Gold, MineStat, Street Insider, Research Pool, Investing News, Stockhouse, MarketBeat, GuruFocus, Morningstar, The Prospector News, and Equity Clock reported beforehand on Corvus Gold, Inc. (CORVF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Corvus Gold, Inc. acquires, explores, and develops mineral properties primarily in the USA. Its mandate is to become a leading exploration and development company with the ultimate goal of becoming a non-operating gold producer with significant carried interest and royalty exposure. The Company’s chief mineral property is the North Bullfrog Project. This is a gold-silver mining project in northwestern Nye County, Nevada. Corvus Gold has its corporate office in Vancouver, British Columbia. The Company’s shares trade on the OTC Markets Group’s OTCQX.

The North Bullfrog Project consists of leased, patented, and unpatented mining claims covering an area of about 86.6 km2 comprising a mix of private mineral leases of patented federal mining claims and 1,057 federal unpatented mining claims. The Project is 10 km north of Beatty, Nevada, and 8 km north of the Bullfrog Mine previously operated by Barrick Gold Corporation. The North Bullfrog Project represents a large, low-sulphidation, epithermal bulk-tonnage gold system hosted in volcanic and sedimentary rocks. The project is 100 percent controlled by Corvus Gold.

In addition, Corvus Gold has its Mother Lode Project. This Project is 165 km northwest of Las Vegas, Nevada, 10 km east of Beatty, Nevada, and roughly 20 road km’s from Corvus’ North Bullfrog project in the Walker Land gold belt. The Mother Lode Project consists of 445 federal unpatented mining claims covering an area of approximately 36.5 km².

Recently, Corvus Gold announced it received assay results from additional stepout drill holes testing the western extension of the Sierra Blanca Deposit on the North Bullfrog project, Nevada. Results continue to expand mineralization, which has shown potential for the North Bullfrog deposits to be developed as a multi-phase, low strip, open-pit heap leach project. This present drill program is evaluating the extension of the regional scale gold system that in the current gold price environment is an attractive target given the large size potential.

The Phase-1 focus of the plan is concentrated on the high-grade oxide vein system at YellowJacket and surrounding north Sierra Blanca area of the North Bullfrog project. This is where baseline environmental permitting is well advanced and important infrastructure is in hand - power and water.

Newly identified mineralization to the west is usually shallow. In the case of holes NB19-469 (39.6m @ 0.71 g/t Au) and NB19-470 (6.1m @ 1.05 g/t Au) they are associated with fine stockwork quartz veins that are normally distal to a YellowJacket type system. The two holes are the farthest west holes drilled so far. They may indicate the potential for another structurally controlled vein system under the pediment to the west.

Corvus Gold, Inc. (CORVF), closed Tuesday's trading session at $1.57, up 3.2895%, on 29,062 volume with 73 trades. The average volume for the last 3 months is 47,936 and the stock's 52-week low/high is $1.12999999/$2.31949996.

chart

DATATRAK International, Inc. (DTRK)

Zacks, OTC Markets, Whale Wisdom, Investing.com, Stockwatch, PR Newswire, TMXmoney, TradingView, Stockopedia, Last10k, Stockhouse, InvestorsHub, MarketBeat, Dividend Investor, Market Screener, Equity Clock, and Stock2Own.com reported beforehand on DATATRAK International, Inc. (DTRK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

DATATRAK International, Inc. is an international Software-as-a-Service (SaaS) provider and innovation leader of cloud-based technologies for the life sciences industry. It delivers unified eClinical solutions and related services for the clinical trials industry. The Company empowers its users with operational efficiency for their clinical trial process. This gives them the ability to control and speed up the outcome of any clinical trial. A worldwide technology and services company established in 1991, DATATRAK International has its head office in Mayfield Heights, Ohio. The Company lists on the OTC Markets.

DATATRAK International built its multi-component, wide-ranging solution on a single, unified platform. DATATRAK delivers a complete portfolio of software products designed to hasten the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies.

The Datatrak Enterprise Cloud supports Pre-clinical and Phase I - Phase IV drug and device studies in manifold languages globally. The Datatrak Enterprise Cloud includes Business Intelligence, CTMS, Trial Design, Electronic Data Capture (EDC), Medical Coding, Risk-Based Monitoring, ECG Data Capture, Image Data Capture, Endpoint Adjudication, Randomization, Clinical Supply Inventory, eConsent, ePRO, and eCOA.

Today, DATATRAK International announced that because of expanding interest and engagements of E-Clinical Platform discussions, the Company will be exhibiting the Datatrak Enterprise Cloud at the 16th DIA Japan Annual Meeting in Tokyo, Japan. Datatrak product experts will be on hand in support of their APAC partners. They will provide product demonstrations of the Enterprise Cloud platform including Business Intelligence, CTMS, EDC Image Capture, Centralized Endpoint Adjudication, eSource and ePRO, all available in Kanji, Traditional Chinese and Simplified Chinese.

Mr. Jim Bob Ward, Chief Executive Officer and President of DATATRAK International, said, "Throughout the year I have presented at regional, national and international conferences on the topics of Predictive Analytics, ePRO and Wearable Devices, and Embedding Analytics in Cloud Platforms. Through our ACRP, SCDM, and DIA China audience interactions and responses from demonstrations at SCOPE and DIA USA, we hear excitement over the value our technology platform offers in reducing the operational costs of integrating redundant stand-alone systems."

DATATRAK International, Inc. (DTRK), closed Tuesday's trading session at $5.45, off by 0.909091%, on 3,495 volume with 12 trades. The average volume for the last 3 months is 573 and the stock's 52-week low/high is $2.30999994/$8.00.

chart

Horizons Holdings International, Corp. (HZHI)

All Penny Stocks, Stock Scores, All Stocks Today, EquityNet.com, OTC Markets, TipRanks, Market Wire News, Stockhouse, MarketWatch, PRWeb, InvestorsHub, Morningstar, Dividend.com, GuruFocus, Seeking Alpha, TradingView, Wallet Investor, Dividend Investor, Stockwatch, Market Screener, and PR Newswire reported earlier on Horizons Holdings International, Corp. (HZHI), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Horizons Holdings International, Corp. operates as a holding, development and investment company. Its purpose is to enable the acquisition of existing companies and provide additional capital and expertise to boost revenue and profitability of the acquired companies. The Company previously went by the name Horizon Health International Corp. It changed its name to Horizons Holdings International, Corp. in April of 2015. The Company lists on the OTC Markets and is headquartered in Las Vegas, Nevada.

Horizons Holdings International works to maintain an inventory of premier investment opportunities. At present, its emphasis is on the development of its wholly owned subsidiary, Pai-Tech. Pai-Tech has developed a brand-new Bot Operating System Standard (B.O.S.S.). It provides a digital workforce of intelligent and intuitive bots. PAI-BOSS provides a distributed operating system powered by PAI-BOTS. These run advanced AI (Artificial Intelligence) algorithms and offer real-time, autonomous, and also distributed solutions.

Pai’s intelligent bots are able to work in any sector and industry. They provide businesses increased levels of cybersecurity and save companies valuable time and money through decreasing workforce costs, avoiding human errors, increasing the quality of work and enabling data to be read in real-time. Furthermore, Pai’s system is a 24/7 operation, is quantum safe, offers customizable scalable solutions, and has a short payback (ROI) period.

In September, Horizons Holdings International confirmed that its subsidiary, Pai-Tech Artificial Intelligence Ltd., signed an OEM (original equipment manufacturer) distribution agreement with Real Time ltd. to develop and distribute products based on PAI's Bot Operating System Standard (PAI-BOSS). Real Time has already developed a distributed and automated solution for the HR field, HR-BOT. It has been installed in the Israeli government and is going to be sold internationally to enterprise corporations and governments.

Pai-Tech Artificial Intelligence has developed a portfolio of Intellectual Property (IP) and has filed a number of patents to the USPTO (United States Patent and Trademark Office). Pai-Tech makes computers smarter via the power of intelligent bots. The company is pioneering computer software with the development of the world's first Bot Operating System Standard (B.O.S.S.).

Earlier in October, Horizons Holdings International disclosed that its subsidiary, Pai-Tech Artificial Intelligence, co-led the technical development with The Floor for their proprietary Idea Generation Engine called the Discovery platform. The Discovery platform was developed benefiting from Pai-Tech's distributed Operating System (PAI-BOSS).

PAI-BOSS provides the ability to distribute data for better security, distribute workload for better performance, and provides a distributed network architecture to ensure data isolation and protection for each user. The Discovery platform is one of The Floor's proprietary tools for empowering tier-1 banks throughout their digital transformation. The Floor's exclusive ecosystem of Banking Partners has benefited from faster technology adoption and access to market-leading solutions.

Horizons Holdings International, Corp. (HZHI), closed Tuesday's trading session at $1.11, up 26.1364%, on 96,925 volume with 200 trades. The average volume for the last 3 months is 33,570 and the stock's 52-week low/high is $0.059999998/$2.02999997.

chart

Innovus Pharmaceuticals, Inc. (INNV)

NetworkNewsWire, Zacks, Stockaholics, Insider Financial, Stockhouse, GlobeNewswire, Simply Wall St, 4-Traders, Street Insider, Micro Cap Daily, Stockwatch, StreetWise Reports, MarketBeat, and OTC Markets reported previously on Innovus Pharmaceuticals, Inc. (INNV), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Innovus Pharmaceuticals, Inc. is an emerging commercial-stage pharmaceutical company listed on the OTC Markets’ OTCQB. It delivers safe, innovative and effective over-the-counter (OTC) medicine and consumer care products to improve men’s and women's health and respiratory diseases. It has products for a range of indications. These include Brain Health, Diabetes, Fertility, Men’s Health, Pain Management, Respiratory, Vitality, Vision, and Women’s Health. The Company’s commitment is to being a leader in developing and marketing new OTC and branded Abbreviated New Drug Application (ANDA) products. Formed in 2008, Innovus Pharmaceuticals has its corporate office in San Diego, California.

Innovus is pursuing opportunities where existing prescription drugs have recently, or are expected to, change from prescription (Rx) to OTC. The Company delivers unique and innovatively presented and packaged health solutions through its OTC medicines and consumer and health products. It markets these directly, via commercial partners to primary care physicians, urologists, gynecologists and therapists, and directly to consumers via its on-line channels, retailers and wholesalers.

Last month, Aytu BioScience, Inc. (AYTU) and Innovus Pharmaceuticals announced that the companies signed a definitive merger agreement. With this agreement, Aytu BioScience will retire all outstanding common stock of Innovus Pharmaceuticals for an aggregate of up to $8 million in shares of Aytu common stock, less certain deductions, at the time of closing. Aytu BioScience is a specialty pharmaceutical company centered on commercializing novel products that address significant patient needs.

Combined, Aytu BioScience and Innovus Pharmaceuticals produced greater than $31 million in revenue over the preceding four reported quarters ending June 30, 2019. The transaction, expected to close as early as Aytu BioScience’s second fiscal quarter of 2020 (quarter ending December 31, 2019) is subject to customary closing conditions and regulatory approvals.

Dr. Bassam Damaj, Ph.D., President & Chief Executive Officer of Innovus Pharmaceuticals, stated, “This is an exciting inflection point for Innovus and our shareholders as we combine with Aytu to strengthen our market position and provide a growth platform for the company and our products. We are looking forward to helping build Aytu into a world-class healthcare company, and I’m personally excited about continuing on as the President of the Aytu Consumer Health business unit.”

Innovus Pharmaceuticals, Inc. (INNV), closed Tuesday's trading session at $1.95, up 1.5625%, on 966 volume with 4 trades. The average volume for the last 3 months is 6,861 and the stock's 52-week low/high is $1.04999995/$12.5895004.

chart

Jushi Holdings, Inc. (JUSHF)

NetworkNewsWire, Market Seat, NIC Investors, Penny Stock Hub, Green Market Report, Cash Crop Today, InvestorX, Street Insider, Stockwatch, MarketWatch, Stockhouse, and Nasdaq reported previously on Jushi Holdings, Inc. (JUSHF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Jushi Holdings, Inc.’s corporate mission is to create an integrated worldwide community of wellness, mindfulness and connections via superior quality cannabis and hemp-derived products. The Company is a globally-focused, multi-state cannabis and hemp operator. Established in 2018, Jushi Holdings is based in Boca Raton, Florida. The Company lists on the OTC Markets Group’s OTCQX.

Jushi is working to be a foremost, new, multi-state owner and operator of cannabis licenses. An industry leading management team leads the Company. Jushi, in the U.S., concentrates on building a multi-state portfolio of branded cannabis and hemp-derived assets via opportunistic acquisitions, distressed workouts, as well as competitive applications.

By way of its subsidiaries, Jushi Holdings engages in the manufacture, possession, use, sale, and distribution of cannabis under the Mend brand in the recreational and medicinal cannabis marketplace. The Company owns and operates cannabis and hemp licenses in the U.S.

Last month, Jushi Holdings announced the closing of its earlier announced acquisition of the majority of the membership interests in Dalitso LLC, a Virginia -based pharmaceutical processor for medical cannabis extracts. At present, Dalitso is one of only five applicants to receive conditional approval for a permit issued by the Virginia Board of Pharmacy to cultivate and process medical cannabis, and to dispense and deliver CBD (cannabidiol) oil and THC-A oil extracts in Virginia. Dalitso's conditional approval is for the northeast region of Virginia, encompassing roughly 28.2 percent of the State's total population. The Company is developing a facility in Prince William County, near the City of Manassas.

Yesterday, Jushi Holdings announced the appointment of Mr. Ian Farrell as Vice President of Compliance and Dr. Pam Baxter as Vice President of Quality. Mr. Farrell will leverage his background in law, finance, and business to ensure cross-departmental compliance via continuous communication, management of company policies, and guidance of legal requirements. Dr. Baxter will advocate quality control and assurance across the whole manufacturing process, ensure all products adhere to the quality expected from an industry leader, and ensure that the manufacturing processes exceed all quality expectations.

Mr. Farrell joins Jushi Holdings from Native Roots Cannabis Co. where he served as Director of Compliance. Native Roots is a manufacturer and distributor of cannabis and hemp products. Dr. Baxter joins Jushi Holdings from Charlotte's Web Holdings, Inc. where she served as Director of Quality and Regulatory Affairs. Charlotte's Web is a producer and distributor of whole-plant hemp CBD extract products.

Jushi Holdings, Inc. (JUSHF), closed Tuesday's trading session at $1.50, off by 2.5974%, on 15,286 volume with 61 trades. The average volume for the last 3 months is 40,339 and the stock's 52-week low/high is $0.25999999/$2.51810002.

chart

Tofutti Brands, Inc. (TOFB)

Zacks, Simply Wall St, 4-Traders, Financial Content, Stockhouse, Stock Invest, Wallet Investor, Market Screener, Dividend Investor, Marketbeat, Capital Cube, and InvestorsHub reported earlier on Tofutti Brands, Inc. (TOFB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Tofutti Brands, Inc. develops and distributes a complete line of plant-based products. It sells greater than 35 milk-free foods. These include cheese products, frozen desserts, as well as prepared frozen dishes. The Company’s products are available throughout the U.S. and in over 30 countries. Tofutti Brands answers the call of millions of people who are allergic or intolerant to dairy, diabetic, kosher or vegan, and also those who desire to have a healthier low-fat diet. OTCQB-listed and founded in 1981, Tofutti Brands is headquartered in Cranford, New Jersey.

The Company’s product line includes plant-based ice cream pints, cones, Tofutti Cutie® sandwiches and novelty bars. In addition, Tofutti sells a prepared food entrée, Mintz's Blintzes®, made with Tofutti's milk-free cheeses such as Better Than Cream Cheese® and Sour Supreme®.

All of the Company’s products are certified Kosher Parve. This means that none of its products ever contain any dairy whatsoever. This means no milk by-products either, such as casein, whey, skim milk powder, or dairy lactic acid. Tofutti Brands sells its products via independent unaffiliated food brokers to distributors, and on a direct basis to retail chain accounts or to warehouse accounts that directly service chain accounts.

Recently, Tofutti Brands issued its results for the Fiscal Year (FY) ended December 29, 2018. It reported Net Income of $507,000 ($0.10 per share) on Net Sales of $13,066,000 for the FY ended December 29, 2018, versus Net Income of $704,000 ($0.14 per share) on Net Sales of $14,107,000 for the FY ended December 30, 2017.

Sales of vegan cheese products decreased to $10,811,000 in fiscal 2018 from $11,237,000 in fiscal 2017. Sales of the Company’s frozen dessert and frozen food product lines decreased to $2,255,000 in fiscal 2018 from $2,870,000 in fiscal 2017.

Mr. David Mintz, the Chairman and Chief Executive Officer of Tofutti Brands, said, “Despite a number of events that impacted the sales of our Better Than Cream Cheese, Sour Supreme and frozen dessert products, we were able to report net income of $507,000 in fiscal 2018. We believe that these issues are substantially behind us. We plan to introduce our new Dippity Do Dah Cheese Dips and reintroduce our Tofutti MarryMe Bars, Chocolate Fudge Treats, and Totally Fudge Pops in the second quarter of 2019 in time for the summer season and look forward to a better 2019.”

Tofutti Brands, Inc. (TOFB), closed Tuesday's trading session at $1.85, up 14.1975%, on 600 volume with 2 trades. The average volume for the last 3 months is 1,673 and the stock's 52-week low/high is $1.45000004/$2.78999996.

chart

Patriot Gold Corp. (PGOL)

Investopedia, The Street, Proactive Investors, Stockwatch, Barchart, Dividend Investor, YCharts, Wallet Investor, Real Pennies, OtcWizard, Standout Stocks, Marketwired, and Gold Investment Letter reported beforehand on Patriot Gold Corp. (PGOL), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Patriot Gold Corp. is a precious metals exploration and production company listed on the OTC Markets’ OTCQB. Its mission is to discover and develop significant gold and silver assets in Arizona and Nevada. Currently, the Company holds a portfolio of four projects. These are the Moss project in Arizona and three in Nevada (Bruner, Vernal, and Windy Peak). Patriot Gold is based in Las Vegas, Nevada.

The Company holds a 3 percent royalty in the Moss Mine in Arizona, an interest in the Bruner gold project in Nevada, and a 100 percent interest in the Windy Peak and Vernal projects in Nevada. The Moss Mine Project is within the historic Oatman District, 10 miles east of Bullhead City, Arizona and roughly 70 miles southeast of Las Vegas. Northern Vertex Mining Corp. is the owner of the Moss Mine. The Moss Mine entered commercial production as of the beginning of September 2018.

The Vernal gold project is in its early stage. This property is approximately 140 miles east-southeast of Reno, Nevada, on the west side of the Shoshone Mountains. This property comprises 12 unpatented mining claims (240 acres).

The Windy Peak Gold Project comprises 79 unpatented mineral claims in the Fairview mining district in southwest Nevada. Windy Peak is easily accessed. It is about 45 miles southeast of Fallon and 6 miles from Middlegate.

Patriot Gold owns a 2 percent royalty in the Bruner gold project. The Bruner gold project property is approximately 130 miles east-southeast of Reno, Nevada. It is at the northern end of the Paradise Range and 45 miles northwest of the Round Mountain Mine. Canamex Resources Corp. is the owner of the Bruner gold project.

The Bruner and Vernal gold projects are in Nevada's Walker Lane, which hosts many major deposits. These include the Goldfield (more than 5 million ounces of post production and current reserves) and the Comstock (more than 8 million ounces).

Recently, Patriot Gold announced that it completed an initial phase of drilling exploration at the Windy Peak Project in Churchill County, Nevada, beginning in September 2018. At present, the Windy Peak deposit is interpreted as a low-sulfidation, epithermal gold deposit positioned marginal to and likely associated with a caldera ring fracture zone.

Intersections between ring fractures and regional normal faults in the Windy Peak Project area are especially favorable exploration targets. They offer the unique combination of fluid conduits and structural controls known to concentrate high-grade mineralization.

Patriot Gold Corp. (PGOL), closed Tuesday's trading session at $0.0575, up 33.7209%, on 1,000 volume with 1 trade. The average volume for the last 3 months is 14,676 and the stock's 52-week low/high is $0.038199998/$0.150000005.

chart

EOS, Inc. (EOSS)

OTC Markets, Barchart, Stockhouse, InvestorsHub, 4-Traders, The Street, Wolf Street, Dividend Investor, Seeking Alpha, Morningstar, MarketWatch, last10k, Stockopedia, Wallet Investor, Real Investment Advice, and Trading View reported earlier on EOS, Inc. (EOSS), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

EOS, Inc. has a broad distribution network of associates with many dealer companies providing health care, beauty care, and environmentally friendly cleaning products in Asia. Since Q1 of 2017, the Company has expanded its marketing channels in China and Southeast Asian countries. Formed in 2015 and OTCQB-listed, EOS is headquartered in Taipei, Taiwan.

The Company previously acquired all of the issued and outstanding shares of Emperor Star International Trade Co. Ltd. (effective May 3, 2017). This is the trading team that plays a vital part in the supply chain of EOS products. EOS acquired Emperor Star trading company in Taipei, Taiwan to strengthen its business and prepare for the challenge of OBOR (One Belt and One Road) development in Malaysia, Indonesia, Thailand, and Cambodia. Emperor Star has been distributing highly unique health and beauty care products and environmentally friendly cleaning products, with first-rate growth in China and Asia.

EOS focuses on the marketing and distribution of skin care products to resellers in Taiwan. It engages in the distribution and marketing of skin care products manufactured by A.C. (USA), Inc. Its products include moisturizers, serums, cleansers, and toners. Products also include exfoliators, acne and oil correctors, facial masks, cleansing devices, and sun care products.

In 2017, Mr. Ben Yang, the chief representative of Asian market, EOS, Inc., signed agency contracts in Nanning City, Guangxi, China, with three owners of new flagship stores launched there. There are four flagship stores set up in China. This includes the first one in Quanzhou. This will help contribute to growing the business of EOS in China. Nanning City is the largest economy of Guangxi province.

On November 30, 2018, EOS signed a contract with A-Best Company and commenced to march toward the worldwide 3C market. A-Best Company is a foremost manufacturer of advanced Piezoelectric Ceramic Speakers.

The collaboration contract was signed by Mr. Yang He-Hsiang, President of EOS, and Mr. Lai Ying-Min, President of A-Best Wire Harness & Components Co., Ltd., at Gloria Prince Hotel in Taipei, Taiwan. The focus of this collaboration is on promoting A-Best Company's patented products, Piezoelectric Ceramic Speakers, and developing more value added products to the international 3C market.

EOS, Inc. (EOSS), closed Tuesday's trading session at $2.40, up 50.00%, on 500 volume with 3 trades. The average volume for the last 3 months is 233 and the stock's 52-week low/high is $0.550000011/$3.50.

chart

GT Biopharma, Inc. (GTBP)

NetworkNewsWire, Stockhouse, Infront Analytics, MarketWatch, The Street, Stockopedia, PR Newswire, GuruFocus, InvestorsHub, Insider Financial, Market Screener, OTC Markets, Morningstar, YCharts, Street Insider, and Simply Wall St reported previously on GT Biopharma, Inc. (GTBP), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

GT Biopharma, Inc. focuses on unique drugs for the treatment of cancer and CNS diseases (Neurology and Pain), along with other unmet medical needs. The Company’s lead oncology drug candidate is OXS-1550 (DT2219ARL). It owns the worldwide rights to commercialize OXS-1550. GT Biopharma is based in Tampa, Florida and the Company lists on the OTC Markets’ OTCQB.

GT Biopharma concentrates on innovative treatments based on its proprietary NK-engager and Bispecific Antibody Drug Conjugate platforms. The Company is targeting multiple myeloma, triple-negative breast cancer, non-Hodgkin’s lymphoma, and more. It is doing so with highly potent biopharmaceutical drugs designed for targeted therapy. Its current CNS pipeline products include treatment for neuropathic pain, the symptoms of myasthenia gravis, and motion sickness.

GT Biopharma’s CNS platform focuses on acquiring or discovering and patenting late-stage, de-risked, and close-to-market improved treatments for CNS diseases. Furthermore, the CNS platform focuses on guiding the products through the Food and Drug Administration (FDA) approval process to the NDA.

OXS-1550 is an ADC (Antibody Drug Conjugate) drug. What makes OXS-1550 (DT2219ARL) different from other treatments, such as chemotherapy, is that the design of it is to specifically target and kill cancer cells while reducing damage to normal tissues. OXS-1550 has demonstrated success in early human clinical trials in patients with relapsed/refractory B-cell lymphoma or leukemia. When OXS-1550 binds to cancer cells, the cancer cells internalize the drug and are killed due to the action of cytotoxic payload. 

Researchers at the University of Minnesota Masonic Cancer Center developed the OXS-3550 TriKE technology. This targeted immunotherapy directs immune cells to kill cancer cells while decreasing drug-related toxicity.

Recently, GT Biopharma announced that it presented data demonstrating the effectiveness of its Tri-specific Killer Engagers (TriKEs) for the treatment of acute myeloid leukemia (AML) presented at the American Society of Hematology (ASH) Annual Meeting.

Raymond Urbanski, M.D., Ph.D., Chief Executive Officer of GT Biopharma, said, “We continue to be encouraged by the data from our Trike program being conducted by leading NK cell experts at the University of Minnesota. These findings have supported us with the confidence to proceed with our first-in-class TriKE, Phase 1 study.”

GT Biopharma, Inc. (GTBP), closed Tuesday's trading session at $0.24, up 26.3158%, on 1,041,425 volume with 313 trades. The average volume for the last 3 months is 70,800 and the stock's 52-week low/high is $0.125/$1.88999998.

chart

Inception Mining, Inc. (IMII)

Stock Commander, Dividend Investor, Investors Hangout, Marketwired, Simply Wall St, Barchart, Streetwise Reports, PennyStocks24, Information Solutions Group, Charms Investments, YCharts, Street Insider, and 4-Traders reported earlier on Inception Mining, Inc. (IMII), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Inception Mining, Inc. engages in the acquisition, exploration, and development of precious metal properties -  chiefly gold-related. Its primary target properties are those that have been the subject of historical exploration having considerable supporting data. OTCQB-listed, Inception Mining is headquartered in Murray, Utah.

The Company holds interest in the U.P. and Burlington Gold Mine. This includes two Federal patented mining claims in the County of Lemhi, Northwest of Salmon, Idaho. The U.P. and Burlington Mine is within the Salmon National Forest. The mine is considered to be within the Eureka Mining District. 

Clavo Rico Ltd. is Inception Mining’s wholly-owned subsidiary. It assumed management control of Clavo Rico’s operation, the Cerros Del Sur operation in Honduras, Central America. Clavo Rico has principal operations in Honduras. Clavo Rico operates two subsidiaries and holds other mining concessions. Inception Mining’s main mine is situated on the 200 hectare Clavo Rico Concession, in southern Honduras.

Inception Mining continues to make improvements in operations and recovery, along with increasing its ore resources at the Cerros del Sur operation. Mine management has secured more mineable properties on its concession. Several adjacent landowners have placed the surface rights of their lands under contract with the mine.

Inception Mining announced in August of 2014 that it entered into an Ore Processing Agreement with New Jersey Mill Joint Venture (NJ Mill), a floatation mill that can process 360 metric tonnes per day. The mill is in Kellogg, Idaho. NJ Mill will process Inception Mining's bulk samples.   

In October 2017, Inception Mining announced that it entered into a Joint Venture (JV) Agreement with Corpus Mining and Exploration Ltd., a company domiciled in the Turks and Caicos. The JV creates a new company, Corpus Gold LLC.

In September 2018, Inception Mining announced that it entered into a verbal cooperation agreement with Glen Eagle Resources, Inc. Under the terms of the cooperation agreement, Glen Eagle will process certain high-grade material contained in sulfides produced at the Clavo Rico Mine that cannot be heap leached at the Clavo Rico Mine site but can undergo processing at Glen Eagle’s Cobro Oro de Honduras processing facility. This cooperation agreement is beneficial for both companies because it enables the processing of certain high-grade material for processing that may not otherwise be processed.

Inception Mining, Inc. (IMII), closed Tuesday's trading session at $0.07, up 34.6154%, on 53,563 volume with 11 trades. The average volume for the last 3 months is 21,605 and the stock's 52-week low/high is $0.000199999/$0.550000011.

chart

ULURU, Inc. (ULUR)

Equity Clock, OTC Markets, Innovative Marketing, The Street, Market Screener, GuruFocus, MarketWatch, SmallCapVoice, Zacks, Marketbeat, BabyBulls, Endocrinology Advisor, and TopPennyStockMovers reported earlier on ULURU, Inc. (ULUR), and today we report on the Company, here at the QualityStocks Daily Newsletter. 

ULURU, Inc. is a specialty pharmaceutical company headquartered in Addison, Texas. It is focusing on the development of a portfolio of wound management and oral care products. This is to provide patients and consumers improved clinical outcomes through controlled delivery using the Company’s innovative Nanoflex® Aggregate technology and OraDisc™ transmucosal delivery system.  ULURU lists on the OTC Markets Group’s OTCQB. 

ULURU’s strategy is to develop and commercialize a customer-focused portfolio of unique wound care products to treat the different phases of wound healing. In addition, the Company’s strategy involves developing the oral-transmucosal technology and generating revenues via manifold licensing agreements.

ULURU’s Nanoflex® Technology is a new class of material. The design of it is to optimize the wound bed environment and accelerate healing. The Company has its Altrazeal® product.  It developed and commercializes Altrazeal® - a transforming powder dressing with proprietary Nanoflex® technology, for the management of exuding wounds. Altrazeal® is a scientifically engineered advanced wound dressing designed to incorporate the desired features and benefits of the ideal wound dressing.

Altrazeal® is produced as a sterile powder and is unique in application and performance on a moist wound surface. Upon application to a moist wound, the powder interacts with wound exudate and hydrates. Hydration with exudate causes the powder to aggregate irreversibly and form a moist wound dressing that conforms to the surface of a wound bed and seals the wound.  Altrazeal® has demonstrated potential clinical and economic advantages in numerous chronic and acute wounds.

ULURU has its patented delivery strip for whitening teeth, which completely erodes - the OraDisc™ W- Erodible Whitening Strip for Teeth. This proprietary tooth whitening product comprises a laminated bilayer strip that uses OraDisc™ technology. 

Additionally, the Company has its OraDisc™A product. ULURU developed OraDisc™ A, a novel mucoadhesive, water-erodible disc incorporating 2mg of amlexanox, for the treatment and prevention of aphthous ulcers. Moreover, the Company’s OraDisc™ B is a mucoadhesive erodible disc containing 15 mg of benzocaine. It was developed for the treatment of oral pain.

ULURU, Inc. (ULUR), closed Tuesday's trading session at $0.03, up 50.00%, on 51,161 volume with 6 trades. The average volume for the last 3 months is 5,646 and the stock's 52-week low/high is $0.010999999/$0.067550003.

chart

OncBioMune Pharmaceuticals, Inc. (OBMP)

MissionIR, Otcstockexchange, Whisper from Wall Street, and Journal Transcript reported on OncBioMune Pharmaceuticals, Inc. (OBMP), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

OncBioMune Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It engages in the development of targeted cancer therapies, a proprietary cancer vaccine technology, and commercialization of a portfolio of products globally. OncBioMune has a proprietary Vaccine Technology designed to stimulate the immune system to attack its own cancer while not hurting the patient. The Company incorporates scientifically proven and clinically validated treatments for cancer. OncBioMune Pharmaceuticals is based in Baton Rouge, Louisiana. The Company lists on the OTCQB.

OncBioMune Pharmaceuticals’ lead product is ProscaVax™. This is its novel cancer vaccine for prostate cancer. ProscaVax is now undergoing evaluation in a Phase 1 clinical study at the University of California San Diego Moores Cancer Center and Veterans Hospital in La Jolla, California, funded in part by the Department of Defense US Navy Cancer Vaccine Program.

ProscaVax consists of a combination of prostate cancer associated PSA with the biological adjuvants interleukin-2 (IL-2) and granulocyte-macrophage colony-stimulating factor (GM-CSF).

Moreover, the Company has a portfolio of targeted therapies. Some of these are biosimilars to blockbuster drugs. OncBioMune has developed the therapeutic cancer vaccine for prostate cancer patients using similar techniques developed for breast cancer patients.

OncBioMune states that it is tested and laboratory proven and that it could become the standard of care for prostate cancer treatment. OncBioMune Pharmaceuticals uses patented technology developed and or acquired by the Company.

In September 2017, OncBioMune Pharmaceuticals announced that it successfully attained development milestones in formulation and stability with tretinoin, also known as all-trans retinoic acid (ATRA). This is an oral drug for the treatment of Acute Promyelocytic Leukemia (APL). The Company owns the commercialization rights for tretinoin throughout Mexico, Central America, and Latin America.

Recently, OncBioMune Pharmaceuticals provided the latest data from its successfully completed Phase 1 trial of ProscaVax for prostate cancer, suggesting a durable response 31 weeks post-therapy. In the Phase 1 clinical trial, hormone-naïve and hormone-independent recurrent prostate cancer patients with rising prostate specific antigen (PSA) were treated with six intradermal injections of ProscaVax.

Dr. Jonathan Head, Chief Executive Officer at OncBioMune Pharmaceuticals, said, “I’m very excited about this data, as I can’t think of another study to have 75 percent of recurrent prostate cancer patients with rising PSA experience stable disease nearly eight months after therapy ended. .. Now, we have to expand the therapeutic range and increase the number of patients enrolled in mid-stage research, but the data to date certainly is encouraging to provide a safe and effective treatments for the millions of men battling prostate cancer today.”

OncBioMune Pharmaceuticals, Inc. (OBMP), closed Tuesday's trading session at $0.2375, up 18.75%, on 4,383 volume with 4 trades. The average volume for the last 3 months is 4,681 and the stock's 52-week low/high is $0.200000002/$26.25.

chart

The QualityStocks Company Corner

Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF)

The QualityStocks Daily Newsletter would like to spotlight Wonderfilm Media Corporation (OTC: WDRFF).

Wonderfilm Media (TSX.V: WNDR) (OTCQB: WDRFF), a producer of high-quality feature films and episodic television with international appeal, this morning announced the co-marketing of a third-party, $50 million (C$65.9 million) asset-backed debt facility intended to accelerate the pace of the company’s revenue and increase overall production efficiency. To view the full press release, visit http://nnw.fm/GC1Tx. Also today, NetworkNewsWire released a report on the company detailing how investors looking for opportunities in the booming mass media sector will likely find Wonderfilm Media on their radars. Based on current trends, cable and video are out, and streaming video on demand is in. Not so long ago, video rental shops were as ubiquitous as delis.

Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF) main business is the worldwide production of high-quality feature films and episodic television. The Wonderfilm team includes Hollywood veterans who have packaged, produced and delivered several profitable recent films, including “BlacKkKlansman,” “Get Out” and “The Hurt Locker.” Having these individuals on the Wonderfilm team demonstrates the company’s proven access to Academy Award-quality films and upside.

Wonderfilm maintains a continuing $58 million annual production slate to meet the constant and growing need for content worldwide. The company’s risk-averse production process results in predictable and consistent revenue streams.

Soaring demand for content from streaming providers is fueling industry growth. The global media and entertainment market is expected to grow from $1.9 trillion in 2017 to $2.4 trillion in 2022, a five-year CAGR of 4.4%.

The company recently formed Wonderfilm Global, an international film and television sales and distribution joint venture that is expected to generate significant incremental revenue.

Wonderfilm has strong relationships throughout the entertainment industry, which enables cost-effective production budgets and in-demand content creation.

Management Team with Proven Track Records

Kirk Shaw: Over 240 movies and seven television series to his credit. Headed up Canada’s largest independent film and television production company, attaining $100 million revenue two years straight with 8% EBITDA.

Dan Grodnik: Founded Mass Hysteria Entertainment, a publicly traded company, and became its chairman/CEO. Produced over 50 feature films, including “Bobby,” the 2006 Robert Kennedy biographic film.

Shaun Redick & Yvette Yates: $300 million+ USD total production budgets to date with a combined 175 award wins/355 nominations, including 10 Oscar nominations. In 2017 and 2018, they produced two of the most successful Hollywood films of those years: “Get Out” ($255 million USD gross revenue) and “BlacKkKlansman” ($100 million USD gross revenue). Scheduled to produce two to three films per year for Wonderfilm, with the first release slated for October 2020. Committed to the 4% challenge to give more women and women of color the opportunity to direct.

Jeff Bowler: 2017 Emmy Award-winning producer. Vice president of acquisitions and production for The Exchange, one of the top film sales and finance companies in the world. Bowler is the executive for Wonderfilm Global distribution.

Bret Saxon: Through his company, TMP Inc., Saxon created M&A deals worth over US$750 million across 113 countries. Produced several feature films and made-for-television movies, including Wonderfilm’s 2019 movie “Zombie Tidal Wave” for NBC/Universal’s SYFY.

17-Title Movie Slate — Greenlit

Wonderfilm currently has 17 films greenlit with combined budgets totaling $58 million. Wonderfilm production stars include: John Travolta, Nicolas Cage, Guy Pearce, Ryan Phillippe and Anne Heche, to name a few.

Some of the company’s most notable greenlit projects include the horror film “Amityville 1974,” slated for theatrical release in October 2020, and the action film “Inside Game” starring Tyrese Gibson, which will be released to theaters in fall 2020.

The company is also actively developing a number of other new IP projects, including a dramatic biographic feature titled “Life and Times of Steve McQueen,” a film adaptation of the bestselling novel “Merchant of Death” and a television series headed by “CSI: Crime Scene Investigation” creator Anthony Zuiker.

 

Potential for Breakout Success

Wonderfilm movies have the potential for millions of dollars in revenue from the kind of breakout success generated by films like “Saw” and “Get Out,” which would propel Wonderfilm and its revenue streams to a new level. Wonderfilm has several potential breakout films in its development/production queue.

Note: Potential breakout films are not factored into company’s revenue projections.

Base Hits and Home Runs

In tandem with its slate of high-profile films, Wonderfilm continues to finance, produce and deliver many profitable low-risk, lower-budget films that are base hits. Shaun Redick is a home run hitter, and his upcoming Wonderfilm projects are anticipated to be home run hits for the company, while base hits such as “Zombie Tidal Wave” provide a consistent source of revenue.

Recent Industry Breakout Films Include:

  • SAW – $1.2 million budget = $103.9 million in sales
  • Pulp Fiction – $8 million budget = $212 million in sales
  • My Big Fat Greek Wedding – $5 million budget = $250 million in sales
  • Lost in Translation – $4 million budget = $120 million in sales
  • Get Out – $4.5 million budget = $255.5 million sales (Shaun Redick)

Note: Revenue from most of Wonderfilm’s current slate will be recorded on the books in 2020 or 2021.

Recent Wonderfilm Releases

  • Aug. 17, 2019: Co-produced with NBC/Universal, “Zombie Tidal Wave” premièred on the SYFY channel to strong ratings.
  • Aug. 29, 2019: “The Fanatic” starring John Travolta opens in U.S. theaters.
  • Sept. 5, 2019: “Tammy’s Always Dying” premiers at Toronto Film Festival.
  • Nov. 8, 2019: “Primal” starring Nicolas Cage opens in U.S. theaters.

Wonderfilm Global Distribution

At the 2019 Cannes Film Festival, Wonderfilm officially launched Wonderfilm Global, a new film, television and media foreign sales/distribution joint venture with 101 Films and Paul McGowan.

Wonderfilm acquired 51% ownership in the joint venture structure and immediately began attaching its own productions to Wonderfilm Global. The joint venture represents a significant opportunity for Wonderfilm, changing how the company does business.

The intention behind Wonderfilm Global is to keep distribution margins in-house that previously went to other companies. Since most Wonderfilm movies are relatively low-risk and easy to sell because they feature desirable cast and genre, third-party distribution companies were previously earning approximately 10%, plus expenses, on Wonderfilm movies without any level of risk. Now, revenue is generated through presales of Wonderfilm projects and, at times, third-party films. The average Wonderfilm movie is pre-sold for $5million, garnering $500,000 to $750,000 per sale as a commission. These commissions now stay in-house with Wonderfilm Global, and the company expects to sell 10 to 12 third-party films between fall 2019 and fall 2020, generating roughly $6 million in commission income.

A further revenue source is generated from theatrical sales through a 50/50 upside split once the minimum sales threshold is met.

Wonderfilm Global has offices in Vancouver, Beverly Hills, London, Ireland, Seoul and China.

Wonderfilm Business Model

Wonderfilm productions are structured to begin generating a return to the company as soon as the camera starts rolling.

Return Before a Film is Delivered: Producer fee line items are included in each production budget. These range from $50,000 to $500,000, depending on the total budget, and are paid to Wonderfilm most commonly on the first day of principle photography.

Distribution: Wonderfilm Global charges sales and distribution fees within each production budget to cover its presale costs.

Note: Wonderfilm’s productions are all structured to minimize risk by matching budget to funds available.

Return After a Film is Delivered: Unsold presale territories are countries or territories left off of a film’s presale list, either for strategic reasons or because the broadcaster/distributor is waiting to see the completed film. These outside-the-budget distribution sales become Wonderfilm profit centers.

Sales overages once contracted presale threshold is surpassed.

The company’s film library grows with each new production, adding to future sales revenue. Depending on the agreement, exploitation rights for future worldwide sales return to Wonderfilm four or seven years after delivery. As of October 2019, Wonderfilm’s growing film library comprises 18 titles for future exploitation.

Note: The nature of the film business is that box office revenue lags production up to a couple of years.

$50 Million Wonderfilm Production Fund (WPF):

Wonderfilm is in the process of raising $50 million to establish a Wonderfilm Production Fund (WPF). WPF is designed to consolidate traditional production financing models into a single diversified, asset-backed debt instrument.

The WPF is a highly specialized investment vehicle with noncorrelated market returns normally reserved for institutional banks and specialty lenders, and it would pay 8% interest directly from each Wonderfilm movie or series budget and not from corporate funds. These same interest payments are already added to each production budget, as the company currently closes a separate financing for every film. The WPF would significantly streamline Wonderfilm’s production rate, adding revenue more quickly and broadening the yearly production slate.

For fund investors, the WPF is a dedicated production-financing vehicle designed to offer a risk-moderated approach to investing in film finance. The managed process provides structure and reassurance that are normally experienced only when working with an institutional lender that has a dedicated staff and resources.

All projects being financed are for Wonderfilm productions, with the fund collateral fully secured by receivables, including presale contracts, government incentives, or a guarantee from Wonderfilm for any unsecured amounts as may be permitted.

Wonderfilm Media Corporation (OTC: WDRFF), closed Tuesday's trading session at $0.1336, off by 4.5714%, on 45,599 volume with 11 trades. The average volume for the last 3 months is 76,298 and the stock's 52-week low/high is $0.075099997/$0.522199988.

Recent News

chart

INmune Bio Inc. (NASDAQ: INMB)

The QualityStocks Daily Newsletter would like to spotlight INmune Bio Inc. (NASDAQ: INMB).

INmune Bio (NASDAQ: INMB) on Monday announced that Malú Tansey, Ph.D., Professor of Neuroscience and Director of the Center for Translational Research in Neurodegenerative Disease at the University of Florida College of Medicine, presented data that demonstrated the use of INmune Bio’s lead compound, XPro1595, to lessen the exacerbation of Alzheimer’s-like pathology brought on by a high fat and high fructose diet in mice. To view the full press release, visit http://nnw.fm/MUn8I.

INmune Bio Inc. (NASDAQ: INMB) is a diversified clinical-stage immunology company developing novel therapies that target distinct parts of a patient's innate immune system to fight disease. Drug candidates INKmune™ and INB03 may be used to treat cancer while XPro1595 targets neuroinflammation as a cause of Alzheimer's disease. INmune Bio's product platforms utilize a precision therapy approach to promote the body's innate immune response to treat unsolved problems in medicine.

INmune Bio is the first biotechnology company to close an initial public offering (IPO) in 2019 and commence trading on The Nasdaq Capital Market. The company also received a "Part the Cloud" award from the Alzheimer's Association in 2018 which included a $1 million grant to advance INmune Bio's XPro1595 drug candidate.

INmune Bio's product pipeline targets three segments of concern:

  • Alzheimer's disease/dementia claims 5.5 million patients in the United States. INmune Bio views Alzheimer's as an immunologic disease which changes the drug discovery process, changes the way clinical trials are designed, and may provide hope for patients and caregivers.
  • Cancer residual disease which is expected to generate more than 1.7 million new cases yearly with an estimated 609,640 fatalities. INMB believe that converting resting Natural Killer ("NK") cells to primed NK cells, which kill cancerous cells on contact, is an important therapeutic strategy to help clear residual disease.
  • Resistance to immunotherapy. By preventing the proliferation and function of cells that resist immunotherapy, patients should have a stronger immune response to cancer cells and may respond better to other cancer treatments including immunotherapy and live longer.

INmune Bio Drug Candidates and Clinical Programs

INKmune is a biologic delivery system that primes a patient's resting NK cells to kill cancer. INKmune targets residual disease for patients that have completed initial cancer therapy (surgery, radiation and/or chemotherapy) and have a low burden of disease with a high risk of relapse.

In late 2019, INKmune will start enrolling patients in a phase I/II trial for women with relapsed refractory ovarian cancer. In many patients, cancer relapse after seemingly effective cancer therapy is due to a failure of the patients own NK cells to eliminate minimal residual disease ("MRD").

Using a novel mechanism of action and a precision medicine approach, INKmune therapy should enhance NK cells' ability to eliminate residual disease.

INB03 is a checkpoint inhibitor that targets myeloid derived suppressor cells ("MDSC") which can produce an immunosuppressive shield that prevents a patient's own immune system from attacking the cancer. INmune Bio is currently completing a monotherapy INB03 phase I trial in patients with advanced solid tumors. The INB03 program will transition into a combination therapy clinical program in the summer of 2019 to prepare for a phase II trial in patients resistant to checkpoint inhibitors due to increased MDSC.

Treatment with INB03 should eliminate MDSC in the tumor microenvironment to allow checkpoint inhibitors to be therapeutically effective.

XPro1595 targets the microglial immune cells of the brain that are activated in many Alzheimer's disease patients. These microglial cells are a cause of neuroinflammation that can kill nerve cells and promote synaptic dysfunction – the cause of dementia in Alzheimer's.

The three-month, phase I trial is expected to enroll 18 patients in summer of 2019. It is designed to measure traditional and novel biomarkers of inflammation in patients with mild to moderate Alzheimer's disease who have neuroinflammation. The trial is supported by a $1 million "Part the Cloud" grant from the Alzheimer's Association. Inflammation, especially chronic inflammation, is being recognized as an important part of the pathology of many diseases including cancer and Alzheimer's disease.

Management

Dr. RJ Tesi, M.D., INmune Bio co-founder, CEO and acting chief medical officer, has been a licensed physician since 1982 and a Fellow of the American College of Surgery since 1991. He received his medical degree from Washington University School of Medicine in 1982 and has served many roles in several development-stage biotech companies focused on treatment of neurodegenerative diseases, hematologic malignancies, and other inflammatory diseases.

CFO David J. Moss co-founder, has been with the company since its formation in September 2015. He holds an MBA from Rice University and a bachelor's degree in economics from the University of California, San Diego. Moss has founded, funded and taken public various companies in a variety of industries since 1995.

Mark Lowdell, Ph.D. co-founder, has served as the chief scientific officer and chief manufacturing officer at INmune Bio since the company's formation. He is a professor of cell and tissue therapy at University College London where he has led a translational immunotherapy group since 1994. He has also been a director of cellular therapy at the Royal Free London NHS Foundation Trust. He received his Ph.D. in clinical immunology from London Hospital Medical College, University of London in 1992 and is a qualified immunopathologist.

Christopher J. Barnum is director of neuroscience at INmune Bio. Barnum is a neuroimmunologist with broad expertise across neurodegenerative and psychiatric diseases holding multiple positions in academic and industry. His focus has been on translating inflammatory therapies into clinical treatments for neurologic diseases using a biomarker-directed approach. Barnum's research has been supported by the NIH, the Michael J. Fox Foundation, and the Alzheimer's Association. He received his Ph.D. in neuroscience from Binghamton University.

INmune Bio Inc. (OTC: INMB), closed Tuesday's trading session at $5.10, up 3.0303%, on 19,692 volume with 92 trades. The average volume for the last 3 months is 30,738 and the stock's 52-week low/high is $3.50500011/$11.50.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) was featured today in the 420 with CNW by CannabisNewsWire. October 17 marked the one-year commemoration of recreational marijuana legalization in Canada. After the legalization of marijuana in 2018, Canadian regulators were fast in developing regulations for marijuana leaf and oil products. However, it took them longer to establish rules for cannabis products such as edibles, cannabis-infused drinks, and concentrates used in vape pens.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hmep-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.

Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.

In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.

Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.

Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Tuesday's trading session at $0.590195, up 7.3082%, on 65,104 volume with 52 trades. The average volume for the last 3 months is 80,573 and the stock's 52-week low/high is $0.399800002/$1.70000004.

Recent News

chart

Nightfood Holdings, Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings, Inc. (NGTF).

Nightfood Holdings (OTCQB: NGTF), the innovative company addressing America’s $50 billion annual night snacking spend, today announced that it has partnered with Ibotta, the leading consumer goods performance marketing platform with over 10 million monthly active users. According to the update, Ibotta performance marketing campaigns will enable Nightfood to drive new customer trials at a low and fixed customer acquisition price. To view the full press release, visit http://nnw.fm/Nlr0L.

Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving the late-night snacking choices of consumers while solving America’s $50 billion-dollar nighttime snacking problem.

Nightfood Ice Cream

Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in a survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try. Winners of the 32-year-old award have been shown to outperform category sales performance by over 38 percent.

Less than two months since manufacturing their first pint of ice cream, Nightfood has now secured distribution in more than 13 states, and has received extensive media coverage from outlets such as USA Today, Fox Business’ Mornings With Maria, Parents Magazine, The Food Network, MarketWatch, The Washington Post, Business Insider, Bustle, and more.

With the Product of the Year award and millions in media coverage, Management has publicly stated their goal of securing nationwide distribution in over 10,000 retail outlets by March 31, 2020.

Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.

More than 37,000 consumers across the country have already requested coupons for the company’s newly launched Nightfood ice cream by entering a giveaway hosted at NightfoodIceCream.com which includes a chance to win a one-year supply (96 pints) plus a freezer for storage. The coupon program is being run in conjunction with PromotionPod, which has previously conducted successful campaigns for brands such as Chobani, Halo Top, and BodyArmor.

Nightfood Inc. began its nationwide rollout of Nightfood ice cream in February 2019, successfully securing placement in Meijer supermarket locations in the Midwest with a concentration around the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus and Milwaukee. A distribution agreement with New England Ice Cream Corporation (NEIC) will also place Nightfood ice cream in outlets located throughout Massachusetts, Vermont, New Hampshire, Maine, Rhode Island and Connecticut.

Ice cream lovers in northern California will find Nightfood Ice Cream at various upscale, independent retail outlets in and around the San Francisco bay area serviced through a distribution agreement with Wonder Ice Cream Company, which services thousands of retail outlets from Bakersfield north to the Oregon border. Consumers can also purchase Nightfood ice cream online at BuyNightfood.com through the Company’s partnership with IceCreamSource.com.

Ice cream is now the 2nd most popular night snack choice, with almost half of all consumers reaching for ice cream after dark. According to IRI Worldwide, 44 percent of all snack consumption occurs between dinner and bedtime, representing a consumer spend of over $1 billion weekly on nighttime snacks in the U.S. alone. Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for 2017 and beyond.

Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category (http://NightSnacking.com). Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.

MJ Munchies, Inc.

MJ Munchies, Inc., was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the trademarked brand name “Half-Baked” and has entered into a Letter of Intent that allows Global Consortium Inc. (OTC: GCGX) subsidiary Infused Edibles to receive an exclusive license to manufacture and distribute marijuana and CBD-infused products under the Half-Baked brand.

Management believes the Half-Baked brand will give the Company a unique and defensible competitive advantage against other recreational edible brands. The Company believes tremendous opportunities currently exist to launch successful and legally compliant products in this space, and that such opportunities will continue to grow over time.

Management Team

Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company AffiliatePros.com which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.

Jim Christensen, vice president of Nightfood Ice Cream, is the former Vice President of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Jim led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution through supermarket, drug, convenience and other channels. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.

CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.

Advisory Board

The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.

Nightfood Holdings, Inc. (NGTF), closed Tuesday's trading session at $0.2459, up 0.701099%, on 144,611 volume with 35 trades. The average volume for the last 3 months is 148,165 and the stock's 52-week low/high is $0.160099998/$0.920000016.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade (OTCQB: SGMD), a major supplier to the hydroponic cultivation and hemp sectors, today announced the finalization of terms for a definitive agreement between Sugarmade and BZRTH Inc.  Under the agreement, Sugarmade will acquire BZRTH Inc. (“BZRTH”), a leading ecommerce supplier to the rapidly expanding hydroponic agricultural space. To view the full press release, visit http://cnw.fm/wBtm4.

Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6

Sugarmade, Inc. (SGMD), closed Tuesday's trading session at $0.0159, up 27.2%, on 27,358,535 volume with 729 trades. The average volume for the last 3 months is 4,228,364 and the stock's 52-week low/high is $0.00975/$0.134000003.

Recent News

chart

IONIC Brands Corp. (CSE: IONC) (OTC: IONKF)

The QualityStocks Daily Newsletter would like to spotlight IONIC Brands Corp. (OTC: IONKF).

West Coast cannabis holding company IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3) announced in September that it has obtained eligibility from the Depository Trust Company (“DTC”) for its shares on the U.S. OTC Markets (http://cnw.fm/Hc2HJ). To view the full article, visit http://cnw.fm/Grv3q. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. Despite the hype surrounding the launch of the cannabis 2.0 market, the event will not be exciting as it was during the launch of the first marijuana market in Canada because no new cannabis derivative product will be introduced in the market.

IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) is a national cannabis holding company building a multistate portfolio of award-winning premium and luxury brands in the cannabis space. Established in 2015, IONIC Brands has demonstrated its ability to expand and operate multiple cannabis concentrate consumer brands in leading markets across the western United States, with current operations in Washington, Oregon, California and Nevada. The company continues to strategically expand nationwide to remain a leader of the highest-value segments in the cannabis market.

With a focus on quality, responsibility and respectability, IONIC’s product lines are pioneering the changing landscape of cannabis consumption. The company’s refinement practices are a result of a passionate commitment to craft the finest, small-batch cannabis oils and cannabis concentrates in the world – without glycols, glycerins or additives.

IONIC’s Certified Clean program verifies that every product leaving the company’s facilities meets or exceeds state mandates on pesticide testing. The testing is conducted by individually testing every batch which ensures and enhances trust and transparency. IONIC recently paired its Certified Clean program with Lucid Green Inc. and its revolutionary technology platform designed to provide vital safety information. Lucid Green’s technology provides a direct-to-consumer data platform, providing instant access to a library of product specific insights by simply scanning the package’s QR code with a smartphone camera.

Elite Brand Portfolio/Acquisitions

  • IONIC, the company’s flagship recreational branded product, is a stylish and sophisticated premium vape pen line that has earned customer loyalty and a reputation as a consistent Top 10 vape brand in Washington state. IONIC’s immediate product line expansion plans include THC/CBD mixes, low-dose products, high-end edibles, CASK oil and device innovation.
  • WW Agriculture cultivates cannabis outdoors on a 140-acre eastern Washington State farm capable of producing up to 100,000 pounds of cannabis for less than $0.10/gram.
  • ZOOTS, a Washington-based edibles company, utilizes patent-protected ultra-clean CO2 extraction hardware to create proprietary formulations of refined cannabis oils and distillates. Through MedMen dispensaries, Zoots Edibles are currently available in Washington and Colorado and will soon be on shelves at dispensaries in Massachusetts, New York and Pennsylvania.
  • Vuber Technologies hardware produces the best vaporization experience on the market.
  • Vegas M Stick vaporizer pens are distributed to stores in Washington State with plans to expand to Oregon and Nevada.
  • Vegas Valley Growers is a revenue-generating, vertically integrated operation in Las Vegas, Nevada, with a full complement of production, manufacturing and distribution licenses.

IONIC has also acquired two U.S. patents issued to Canna Café that are related to cannabinoid (CBD) infused coffee and CBD-infused coffee in a Keurig ® K-Cup ® Pod. An international patent is in process for cannabis-infused teas.

Experienced Management Team

IONIC Brands is led by an innovative product team, powerful sales organization and a world-class marketing group.

Chairman & CEO John Gorst has built and sold four different technology companies with market valuations in excess of $600 million. Gorst has been at the forefront of IONIC’s expansion and development into Washington state’s leading vaporizer brand.

Andrew Schell, President, Vice-Chairman & Co-Founder, has built several successful companies. Schell has an engineering background rounded in operations, strategy and corporate law, and most recently was CEO of a U.S. Department of Defense company specializing in military operations.

Christian Struzan, Chief Marketing Officer & Co-Founder, has over 30 years of experience in marketing and branding in the entertainment and consumer goods industries. Struzan founded an advertising agency which developed and executed marketing campaigns for feature films such as the Star Wars franchise, Fight Club, and the television series American Idol. He has also worked on global brands such as Guinness, Stella Artois and Beck’s.

Johnny Stange, Chief Revenue Officer, was formerly a director of sales for the southern California region for Treasury Wine Estates, a major wine wholesaler, where he grew and oversaw annual sales of $250 million. Stange is leading the charge in IONIC’s aggressive sales growth plans across multiple states.

In 2018, IONIC was voted one of the “Top 50 Companies to Work for in Cannabis” by MG Magazine, a publication serving cannabis industry professionals.

IONIC Brands Corp. (OTC: IONKF), closed Tuesday's trading session at $0.03, even for the day, on 84,050 volume with 28 trades. The average volume for the last 3 months is 265,891 and the stock's 52-week low/high is $0.019999999/$0.634559988.

Recent News

chart

OriginClear (OTC: OCLN)

The QualityStocks Daily Newsletter would like to spotlight OriginClear (OTC: OCLN).

OriginClear (OTC: OCLN) leads the self-reliant water revolution, deploying advanced technologies at the point of use, with modular, prefabricated systems that create durable assets and water independence for industry, commerce and agriculture. Failing infrastructure and the rising cost of water are driving businesses to treat their own water. OriginClear leads this megatrend with on-premise systems enabling very high purification and recycling levels that centralized systems cannot achieve.

OriginClear (OTC: OCLN) leads the self-reliant water revolution, deploying advanced technologies at the point of use, with modular, prefabricated systems that create durable assets and water independence for industry, commerce and agriculture.

Failing infrastructure and the rising cost of water are driving businesses to treat their own water. OriginClear leads this megatrend with on-premise systems enabling very high purification and recycling levels that centralized systems cannot achieve.

Systems installed at the point of use become productive assets for businesses that also increase property values. And OriginClear helps corporations improve their environmental, social and governance (ESG) standings with world-class water management.

Operations & Markets

OriginClear leads a new generation of water companies that focus on meeting the needs of businesses looking for compact, advanced technologies that can be shipped to and installed at the point of use. The company manufactures and distributes its professional-grade water treatment and conveyance products to commercial and industrial properties, fielding both direct and indirect sales channels to reach end-market clients such as hotels and resorts, real estate housing developments, office buildings, military installations, schools, farms, food and beverage manufacturers, industrial warehouse, oil and gas producers, and medical and pharmaceutical facilities.

From its Texas-based factory, OriginClear designs and prefabricates an entire line of plug-n-play containerized units called Modular Water Systems™ that enable water purification, recycling and wastewater management.


Industrial Pretreatment Waste Water Treatment Plant (WWTP) designed by Daniel M. Early, using reinforced thermoplastic modules.

These onsite modular products provide clients with water independence through ownership and operational control over water quality, enabling them to increase productivity while reducing environmental, health and safety risks from pollution, contamination and corrosion. Modular water products are trusted to balance performance with cost-effectiveness, enabling business users to go well beyond municipal standards for water quality, therefore achieving high levels of satisfaction for their own customers, and improved sustainability for their properties.

OriginClear’s water treatment equipment can boost real estate asset value as a fundamental capital improvement, combined with long-lasting water savings for the corporate bottom line.

Product Portfolio

OriginClear groups its products into three main categories:

  1. Water Treatment: achieving high grade purification.
  2. Water Conveyance: water transportation and pumping.
  3. Advanced Technologies: commercialization of innovative technologies.

OriginClear’s complete line of compact, on-site, point-of-use products include: advanced purification systems that are skid, rack-mounted and containerized for reverse osmosis, ultrafiltration, media filtration, disinfection, water softening, ion exchange and electrodeionization (EDI), combined as needed in small to medium commercial and industrial applications, and custom-build projects. Water conveyance products include pump and lifting stations, modular storage tanks, and control monitoring panels.

OriginClear’s line of modular water products and systems is key to the self-reliant water treatment revolution as they create “instant infrastructure” – fully engineered, prefabricated and prepackaged systems that use durable, sophisticated materials. The units are available in standard capacities for onsite closed-loop systems at commercial business locations.

The company’s rugged wastewater treatment plants, highly reliable pump stations, and premium water purification units typically offer 25 percent lower initial costs over conventional systems, with greater quality and full connectivity. These pump stations and wastewater treatment products utilize high density thermo-plastics (HDPE) and proprietary, innovative prefabrication methods and materials that deliver the longest life and strongest products.

Breakthrough Technologies

OriginClear has a long history of innovation through its OriginClear Technologies division, which is responsible for identifying leading-edge technologies to solve today’s toughest challenges. These advanced technologies are the centerpiece of the division’s international licensee network. The technologies are developed in OriginClear Technologies, and licensees integrate them into their own products.

Electro Water Separation™ (EWS) and Advanced Oxidation (AOx™) are the principal, well-proven technologies.

EWS is OriginClear’s breakthrough water cleanup technology which utilizes a catalytic process to concentrate and eliminate suspended solids in the worst commercial and industrial wastewater.

AOx is OriginClear’s proprietary advanced oxidation technology which generates a dense cloud of ozone, hydrogen peroxide and hydroxyl radicals, dramatically reducing or eliminating dissolved organic microtoxins, including bacteria and viruses, hormones, drugs, pesticides such as Roundup, and synthetics. AOx has also been shown to effectively reduce harmful chemicals such as ammonia and hydrogen sulfide – the “rotten egg” smell in crude oil that reduces its value.

Through international licensing and partnerships, OriginClear’s advanced technologies are being adopted to treat tough water problems in East and South Asia, Europe and the Middle East, and North America.

Market Opportunity

OriginClear is a growth story and positioned to take full advantage of a major shift from the city to the corporate user; while the company is already operating successfully with strong profit margins, an increasing customer base, and working on accretive acquisitions that could dramatically increase growth.

In just 10 years, the global water services market has doubled into a trillion-dollar industry. Yet, only 20 percent of all sewage, and 30 percent of all industrial waste, are ever treated. Water leakage results in the loss of 35 percent of all clean water across the planet; cutting that number in half would provide clean water for 100 million people. This is a situation of great danger, but also great potential.

We can no longer rely on giant, centralized water utilities to meet the challenge. That’s why more and more business users are doing their own water treatment and recycling. Whether by choice or because they have to, those businesses that invest in onsite water systems get a tangible asset on their business and real estate, and can enjoy better water quality at a lower cost.

Out of sight of the general public, self-reliant businesses are quietly building Decentralized Water Wealth™ for themselves while also helping their community. They know that environmental, social and governance (ESG) investing guidelines, which drive about a quarter of all professionally managed assets around the world, specifically include the key factor of how well corporations manage water.


10,000 Gallon per Day Industrial Membrane Bioreactor Waste Water Treatment Plant designed by Daniel M. Early, PE, using long-lived Structural Reinforced ThermoPlastic (SRTP)

OriginClear is a key enabler of ESG water management for corporations that are increasingly responsible for what was once delegated to central utilities. For example, when a corporation manages its own water, and uses OriginClear’s proprietary hybrid treatment methods, it can significantly reduce both water use and nutrient footprints (carbon, nitrogen, and phosphorus) in one compact package.

These hybrid processes feature advanced blackwater treatment with advanced clean water processing. They can convert toxic nutrients to less harmful compounds, and even capture them for beneficial reuse purposes, as shown in OriginClear’s recent case study.

Revenue Growth through Synergy

Since OriginClear acquired it in 2015, Progressive Water Treatment has generated steady revenues in the range of a million dollars a quarter. It is now the Fabrication and Manufacturing Division for the whole company. The team at Modular Water Systems, headed by Chief Engineer Daniel M. Early, is responsible for overall design and high-level engineering. It relies on the Fabrication and Manufacturing Division to add incremental revenue for its modular product line, without requiring large increases in personnel.

OriginClear believes that these two business units can develop growing revenues through synergy and ultimately help achieve overall profitability. OriginClear also seeks to acquire profitable water companies that can complement the synergy of its existing units and accelerate both revenues and profitability. However, acquisitions are neither guaranteed, nor essential to OriginClear’s continued growth.

 

Leadership

OriginClear’s management team brings strong leadership and a background in managing business operations, sales, technologies, and finance. The team combines idealism with solid commercial skills, achieving a triple bottom line of environmental, social and financial gain.

Riggs Eckelberry – Chairman, CEO and Co-founder
Riggs Eckelberry is a veteran technology manager who led companies to multiple exits during the high-tech boom of the 90s and early 2000s. Eckelberry came to the water industry from a quarter century in high technology, specializing in commercializing breakthrough technologies. During the dotcom boom, he worked on a series of tech successes, such as Quarterdeck’s CleanSweep; security software vendor Panda Software; and the sale of companies to EarthWeb, BeFree, and BellSouth. Just prior to founding what is now OriginClear, he helped drive security software company CyberDefender to an IPO on the Nasdaq as its president and chief operating officer.

Thomas Marchesello – Chief Operating Officer
Thomas Marchesello is a business operations and technology executive with over 20 years’ experience in manufacturing and distribution of products and services. He has 12 years in private equity M&A, doing buyside acquisitions of small to midsize corporations. He has over 10 years advising innovative corporations on ESG strategy and speaks often about industry trends. He began his career in the U.S. Air Force, Space Command Headquarters for environmental sciences. He has held key roles for Fortune 500 companies such as Sony, Thompson Reuters, Morgan Stanley, and Chicago Mercantile Exchange.

Daniel M. Early, PE – Senior Engineer
For the past 25 years, Dan Early has worked as an engineered products development specialist with very strong understanding of the complex and interconnected disciplines, economies, and governmental regulation needed to develop and sustain modern civil infrastructure systems that reflect a balance of environmental stewardship, social expectations, and cultural requirements. Since 2010, Early has specialized in the research, development, and deployment of next generation water infrastructure technologies using heavy plastic manufacturing. His initiatives and innovations anchor Modular Water Systems’ product line.

Marc Stevens – Director of Fabrication and Manufacturing
Marc Stevens brings nearly 40 years of experience to OriginClear’s manufacturing team. His experience in mechanical design, equipment fabrication, installation and a wide range of projects led to his founding what is now OriginClear’s Fabrication and Manufacturing Division. He supervises the design, building and installation of customized, large-scale water treatment systems, including purification technologies for process waters for boilers and cooling towers, drinking water and various industrial waste water applications. Stevens leads the team that also manufactures OriginClear’s standardized Modular Water Systems.

OriginClear (OCLN), closed Tuesday's trading session at $0.0002, even for the day, on 45,545,570 volume with 30 trades. The average volume for the last 3 months is 52,861,600 and the stock's 52-week low/high is $0.00009/$0.0048.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was highlighted today in a publication from Financialnewsmedia.com, examining how CBD retail sales just in the U.S. are expected to pass $1 billion – a 133% jump year over year, as noted by the 2019 Hemp & CBD Industry Factbook.  By 2024, sales could balloon to $10 billion.  “The recent surge of consumer demand for CBD, coupled with increasingly easy access to CBD products, is expected to drive retail sales to about $1.1 billion-$1.3 billion in 2019,” said Kristen Nichols, editor of the 2nd Annual Hemp & CBD Industry Factbook.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed Tuesday's trading session at $1.15, off by 4.9587%, on 131,171 volume with 191 trades. The average volume for the last 3 months is 288,005 and the stock's 52-week low/high is $0.843599975/$5.20499992.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organic cannabis, hosted site visits at its Hamilton and Valleyfield facilities for roughly 25 analysts in September (http://cnw.fm/aC9Ly). To view the full article, visit http://cnw.fm/O8LVh. Also today, the company was highlighted in a publication from FN Media Group, examining how ongoing news about tainted cannabis and vaping-related illnesses has put the spotlight on the quality of cannabis products on the market and many consumers are looking to get their hands on premium pot for better quality and taste.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed Tuesday's trading session at $0.83975, off by 4.5875%, on 1,919,423 volume with 783 trades. The average volume for the last 3 months is 998,696 and the stock's 52-week low/high is $0.765500009/$4.38000011.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

Indiva Limited (the "Company" or "Indiva") (TSXV: NDVA) (OTCQX: NDVAF) is pleased to announce it has signed a definitive agreement with The Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) to manufacture and distribute pre-rolls for Supreme Cannabis' portfolio of brands from Indiva's facility in London, Ontario. The Supreme Cannabis portfolio includes recognized premium recreational and wellness brands like 7ACRES, Blissco and KKE. Also today, the company was highlighted in a publication from Financialnewsmedia.com, examining how ongoing news about tainted cannabis and vaping-related illnesses has put the spotlight on the quality of cannabis products on the market and many consumers are looking to get their hands on premium pot for better quality and taste.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Tuesday's trading session at $0.6376, off by 1.9077%, on 216,358 volume with 215 trades. The average volume for the last 3 months is 489,478 and the stock's 52-week low/high is $0.588800013/$1.7888.

Recent News

chart

Geyser Brands Inc. (TSX.V: GYSR)

The QualityStocks Daily Newsletter would like to spotlight Geyser Brands Inc. (TSX.V: GYSR).

Now that cannabis is losing its illegitimacy, derivatives of the plant are permeating consumer markets at a rapidly growing pace, thanks to companies such as Geyser Brands Inc. (TSX.V: GYSR). The global cannabis-powered and science-led consumer health care company offers products in a diverse range of markets, from fast-moving consumer goods and over-the-counter pharmaceuticals to medical cannabis. Also today, the company was featured in a publication from CBDWire, examining how for the past few years, CBD has been riding a wave of good press, owed primarily to the glowing testimonials given by satisfied users. Both derived from the cannabis plant, cannabidiol was often lumped together with its infamous cousin THC, which is responsible for cannabis’ psychotropic high.

Geyser Brands Inc. (TSX.V: GYSR) is a consumer wellness brand cultivator that builds and markets hemp-infused health and wellness products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, baked goods and tincture formulations with superior bioavailability and water solubility. Geyser Brands is rapidly building its revenue-generating operation with a marked milestone in September 2019 with the successful acquisition of Solace Management, a company whose portfolio includes 57 SKUs of consumer wellness goods and pet care products.

Solace recently moved into its new 7,500-square-foot GMP (Good Manufacturing Practices)-compliant facility in Coquitlam, British Columbia, which is expected to trigger up to a 10-fold increase in the company’s production capacity now that it has a Natural Health Product site license from Health Canada. Solace intends to also develop and license new products that are either ready for production or are in various stages of development, since construction of the facility is now complete.

Geyser Brands and Solace welcomed yet another marketable product to their stable with the receipt of an NPN (Natural Product Number) from Health Canada for their hemp-based pain relief roll-on, which means the pain-relief product can now be sold as a natural health product through the company’s Apothecary Naturals line. Health Canada assessed the roll-on and found it to be safe, effective and of high quality when it is used as directed.

NanoFusion Technology

The efficacy of most hemp products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.

Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; and provides longer shelf-life and stability of molecules.

Operations

Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company’s cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.

Geyser Brands’ integrated production chain and formulation lab develops innovative products using high-quality hemp for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and shelf stability while maintaining all-natural ingredients and ensuring premium quality.

Geyser Brands actively explores opportunities to invest in the research and development of unique, high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.

Growing Portfolio

  • Apawthecary Pets – line of products has established itself as leading all-natural hemp-based pet treats with formulations for pet treats, salves and oral drops. Animals, like humans, may suffer from the insomnia, digestive difficulties, pain and inflammation hemp products are designed to relieve a wide variety of conditions. All of Apothecary’s products are made with organic, cold-pressed and unrefined hemp seed oil extract.
  • Apothecary Naturals – 100% all-natural, organic, hemp-based topical products for everything from skin care to pain relief.
  • WildTails – 100% all-natural, freeze-dried, single-ingredient and nano-hemp infused pet foods and treats.
  • Apothecary Ink – Antibacterial skin preparation products, pain control as well as skin care for new and old tattoos.

Management Team

Chairman and Co-Founder, Brad Kersch, brings a strong business background with over 20 years of experience in successful startups and working with Fortune 500 companies. He spent his early years in the advertising and marketing field and went on to form Hyperware, a clothing company that sold branded clothing to retailers across Canada before selling to clothing giant Ocean Pacific (OP). Kersch became the president of Shoreline Studios, Canada’s largest and oldest studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets.

CEO and Co-Founder, Andreas Thatcher, has been CEO of Geyser Brands since the January 2018 and has been a principal at Rhizome Group since 2014, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media investment company specializing in marketing and distribution financing, and worked in the Investment Banking industry in London and Toronto. Thatcher holds a master’s degree in economics.

CFO Gordon Clissold is a Chartered Professional Accountant with over 20 years of experience as an operational and financial manager for both public and private companies. His career experience spans multiple industries that include technology, manufacturing, wholesale distribution, and professional services. Gordon obtained his accounting designation in 1995, was awarded the Fellowship designation in 2006, and has been awarded life membership as Chartered Professional Accountant.

Kuldip Gill, head of Geyser Brands’ R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill’s experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.

Geyser Brands Inc. (TSX.V: GYSR), closed Tuesday's trading session at $0.35, off by 7.8947%, on 7,350 volume with 4 trades. The average volume for the last 3 months is 2,515 and the stock's 52-week low/high is $0.349999994/$0.850000023.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com (CIIX) was featured today in a publication from CBDWire, examining how only once in a while do you come across a medication as versatile as CBD, and it has only taken a short while for word to spread; cannabidiol is the new wonder drug, and everyone wants in on it. UK brand Blockhead has been the latest to join the fray with the launch of what it claims is UK’s first-ever CBD infused chewing gum.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Tuesday's trading session at $0.21, off by 12.50%, on 99,075 volume with 29 trades. The average volume for the last 3 months is 42,141 and the stock's 52-week low/high is $0.208000004/$0.800000011.

Recent News

chart

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Innovative hemp and cannabis corporation Marijuana Company of America (OTCQB: MCOA) today announced that the company has begun its 2019 harvest at its CBD hemp farm in Scio, Oregon. MCOA, with its joint venture partner, Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FRANKFURT: GHG), has created joint venture subsidiary, Covered Bridge Acres Ltd. (“CBA”), which owns the hemp biomass that spans 35 acres and incorporates environmentally-friendly and biodegradable methods.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed Tuesday's trading session at $0.1898, off by 19.8304%, on 886,013 volume with 324 trades. The average volume for the last 3 months is 275,986 and the stock's 52-week low/high is $0.023/$2.10599994.

Recent News

chart

Xalles Holdings Inc. (OTC: XALL)

The QualityStocks Daily Newsletter would like to spotlight Xalles Holdings Inc. (OTC: XALL).

Fintech holding company Xalles Holdings Inc. (OTC: XALL)is citing a recent article on bitcoin trading strategy issued by its revenue sharing agreement partner as a means by which savvy investors can maximize their profits amid the ever-volatile mood swings of the crypto market.

Xalles Holdings Inc. (OTC: XALL) is a fintech holding company leveraging blockchain and other technologies for e-commerce, payments, financial reconciliation, and payment auditing solutions. The company actively seeks acquisition targets with strong management teams and business models, large total attainable markets, and lucrative exit opportunities in which to invest and accelerate growth.

Operations

The common element to all acquired entities and projects is a business model that involves setting up a payment or financial transaction “toll gate,” thereby creating a recurring revenue stream.

Xalles’ business plan focuses on consumer, business and government-oriented payment and financial reconciliation transactions. Combining the blockchain decentralized financial ledger platform with the company’s existing X2X transaction reconciliation system design, Xalles is building technology that supports payment audits, exchanges, and new business models and opportunities worldwide. Xalles will launch new services card and mobile payment and rewards systems, and will expand the technology offerings for referral marketing and e-commerce engines.

Subsidiaries
All current subsidiaries are wholly owned

  • Xalles Holdings
    Raise capital for fintech accelerator program acquisitions, provide management, administrative, finance and marketing support to all subsidiary companies
  • Xalles Capital
    Management support of investment consortiums, direct investment into funds or projects, and management of investments
  • Xalles Limited
    Design and market new X2X solutions; acquire U.S Government transportation post-payment audit business through GSA schedule and expand to non-transportation payment auditing
  • Xalles Technology
    Technical development of the X2X blockchain systems
  • Xalles Financial Services
    Consumer and small business financial service offerings
  • Co-Owners Rewards
    Stock-based rewards system for payments cards and financial services
  • Amazing Living Enterprises
    Affiliate program and e-commerce platform for enhancing financial lives
  • Global Savings Network
    Not-for-profit fundraising system with consumer discounts at local merchants

X2X Solutions

Xalles provides payment and financial transaction management solutions through the company’s proprietary blockchain-based X2X technology. The X2X solution includes the Investment and Financing System (IFS), which supports complex investment structures, assists international investment consortia, and provides links to Xalles’ Financial Transaction Reconciliation (FTR) solution. FTR supports complex financial ecosystems, making it easier for parties to exchange products, services, grants and government incentives, and assists “Exchange Managers” with liquidity and auditability. X2X also supports the Xalles pre- and post-payment auditing services.

Advancements in 2019

  • Co-Owners Rewards subsidiary is working to launch a general purpose reloadable prepaid payment card with a stock rewards program.
  • Previously announced LYC Mortgage acquisition will create a structure that will dramatically increase revenues in 2020 with new mortgage business portfolios.
  • Xalles Financial Services expects to launch the Cryptocurrency Trading Engine and acquire multiple cryptocurrency asset portfolios to drive increases in value through the trading engine.

“The structure and growth plan for the company contains a balance of diversity and synergy so that we can effectively use limited resources to obtain the best results. We will see the culmination of the fundraising efforts, acquisitions and organic growth in the second half of 2019 put us on the path to tremendous growth in 2020.”

– Xalles CEO Thomas Nash (http://nnw.fm/rU6iT)

Xalles Holdings Inc. (OTC: XALL), closed Tuesday's trading session at $0.0031, off by 3.125%, on 22,000 volume with 3 trades. The average volume for the last 3 months is 2,080,060 and the stock's 52-week low/high is $0.0013/$0.021029999.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.